News & Updates

Show Multimedia Only
Post-ICH antiplatelet therapy not linked to recurrent ICH

Post-ICH antiplatelet therapy not linked to recurrent ICH

28 Oct 2021 byRoshini Claire Anthony

Initiating antiplatelet therapy following an intracerebral haemorrhage (ICH) that occurred during antithrombotic use does not lead to recurrent symptomatic ICH, according to extended results of the RESTART* trial.

Post-ICH antiplatelet therapy not linked to recurrent ICH

28 Oct 2021
ULTIMATE: Biologic DMARD affords inflammation control in psoriatic arthritis

ULTIMATE: Biologic DMARD affords inflammation control in psoriatic arthritis

28 Oct 2021
Modified dual therapy on par with recommended regimen in H. pylori infection

Modified dual therapy on par with recommended regimen in H. pylori infection

28 Oct 2021

A modified dual therapy as first-line treatment for H. pylori infection demonstrates equal efficacy and compliance relative to recommended regimens, reveals a study. Moreover, a generally modified dual therapy has fewer side effects.

Modified dual therapy on par with recommended regimen in H. pylori infection

28 Oct 2021